JP Morgan Maintains Overweight on Vistra, Lowers Price Target to $231

Benzinga Newsdesk www.benzinga.com Negative 89.7%

Neg 89.7% Neu 0% Pos 0%

JP Morgan analyst Jeremy Tonet maintains Vistra (NYSE:VST) with a Overweight and lowers the price target from $240 to $231.